Kelly Lyn Warfield

Integrated BioTherapeutics, Inc., USA 0000-0001-6535-0675

Kelly Lyn Warfield began her scientific career as a student intern at the National Institute of Standards and Technologies and the National Cancer Institute, both in Md, USA. Following college at Loyola College Maryland, Md, USA, Dr. Warfield received her Ph.D. degree in molecular virology from Baylor College of Medicine in Houston, Tex, USA, by studying immune responses and pathogenesis of rotavirus infections, as well as investigating adverse events related to rotavirus vaccination and infection, using animal models. Further training during a National Research Council postdoctoral fellowship at the United States Army Medical Research Institute of Infectious Diseases allowed Dr. Warfield to become specially trained in BSL-3 and BSL-4 containment laboratories studying pathogenesis, developing animal models, and vaccines and therapeutics for the highly lethal filoviruses. Currently, Dr. Warfield works in the biotechnology industry at Integrated Biotherapeutics, Inc., Md, USA, as the Vice President of vaccine development and is focused on development of antivirals and vaccines for Ebola and Marburg viruses.

Biography Updated on 25 December 2012

Scholarly Contributions [Data Provided by scopus]

download